A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants
Clinical trial NCT02023255 · COMPLETED
Trial details
- NCT number
- NCT02023255
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-06-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.